Bicara Therapeutics Inc. Common Stock (BCAX) vs OPKO Health, Inc. (OPK)
A side-by-side comparison of Bicara Therapeutics Inc. Common Stock and OPKO Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCAX
Bicara Therapeutics Inc. Common Stock
$16.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OPK
OPKO Health, Inc.
$1.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BCAX vs OPK
growth of $100 · dividends reinvested · last 2yBCAX -26.1% (-14.1%/yr)OPK -1.9% (-0.9%/yr)OPK compounded faster over this window
BCAX OPK
BCAX vs OPK: by the numbers
- •OPK is the larger company ($1.09B vs $1.09B market cap).
- •Both run net losses; BCAX's is the smaller (0.00% vs -12.40% net margin).
Metrics side by side
Valuation
| Metric | BCAX | OPK |
|---|---|---|
| P/S ratio | N/A | 1.85 |
| P/B ratio | 2.32 | 0.92 |
Profitability
| Metric | BCAX | OPK |
|---|---|---|
| Gross margin | 0.00% | 21.10% |
| Operating margin | 0.00% | -36.08% |
| Net margin | 0.00% | -12.40% |
| ROE | -39.54% | -6.16% |
| ROIC | -42.98% | -8.86% |
Growth (annualized)
| Metric | BCAX | OPK |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -21.00% |
| Total return CAGR (5Y) | N/A | -15.39% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.